I agree. If not PR'd in coordination with the FDA
Post# of 148126
Plan B would be be the same except no halt on Friday and release PR afterhours and halt trading Monday morning until after CC.
I understand OTC halts can be requested from the companies (I think NEXCF did this back when the shorts were manipulating their stock last summer), and pending such significant news without the built in "breaker" halts this seems like the prudent thing to do on the OTC. It would allow them to issue initial results, provide time for investors and others to digest the information and address questions without wild unregulated OTC price swings.